there is still no universally acknowledged model for developing CF. In addition, factors other than components in the adipogenic niche that were the focus of this investigation, such as mediators from the gut and lymph vessels, may be capable...
CREBBP/EP300mutations contributed to tumor progression and the aberrant tumor microenvironment in DLBCL As shown in Fig.1a, mutations of chromatin-modifying genes were assessed in 619 patients with newly diagnosed DLBCL (the training cohort (N = 316) by whole-genome/exome sequencing (WGS/WES...